Posts Tagged ‘Biotech’
Merck inaugurates its Biotech Development Centre in Corsier-sur-Vevey
German laboratory Merck invested CHF 250 million in Corsier-sur-Vevey (VD). The 15,700 m2 building will combine research and production of biotechnology drugs and employ 250 people. The pharmaceutical company has invested more than 250 million Swiss francs in this “Biotech Development Centre”. It is dedicated to the development and production of active ingredients for…
Read MoreLonza acquires Dutch biotech company Synaffix
The Valais-based pharmaceutical subcontractor will pay an initial €100 million, with subsequent milestone payments of up to a further €60 million. The deal will strengthen Lonza’s portfolio of antibody-drug conjugates (ADCs) through the integration of Synaffix’s platform. According to a recent estimate relayed by Lonza, the ADC market is set to pass the…
Read MoreHow the flu virus hacks our cells
A UNIGE team has discovered how the influenza A virus hijacks the mechanism for importing iron into cells to invade its host. Influenza epidemics, caused by influenza A or B viruses, result in acute respiratory infection. They kill half a million people worldwide every year. These viruses can also wreak havoc on animals, as…
Read More6 life sciences startups in the Top 10 of the W. A. de Vigier Award
From a record number of over 300 submitted projects, the jury picked their Top 10. On 20 June 2023, up to five of those young leaders will receive a W. A. de Vigier Award, each endowed with CHF 100,000 biped AG from Epalinges (VD) – Independence for the Visually Impaired 270 million visually impaired…
Read MoreBIND: Bioinnovation Day Awards
On 11 May 2023, 31 early stage life sciences projects were presented to the public at the AGORA (Fondation ISREC) near the CHUV in Lausanne, during the Bioinnovation Day. Three of them received and award. The BIND is an event was organised the PACTT, the Technology transfer office of University of Lausanne (UNIL) and…
Read MoreNewBiologix is betting on the industrialization of gene therapy
With CHF 45 million raised, the start-up NewBiologix, officially launched on 11 May 2023 at the Biopôle in Epalinges, has very high ambitions. Its two founders, Igor Fisch and Nicolas Mermod, want to reproduce the model that they had successfully implemented in Geneva with their previous company, Selexis. NewBiologix SA emerged from stealth…
Read MoreBiotech companies thrive in Switzerland
Swiss Biotech Report 2023 shows sector weathers global disruption well and continues to play a leading role driving global healthcare innovation Record revenues of CHF 6.8 billion (USD 7.5 billion) Fundraising of CHF 1.3 billion (USD 1.5 billion) exceeding pre-COVID 19 levels of 2019. CHF 0.78 billion by public companies, CHF 0.55 billion…
Read MoreImpossible Materials raises CHF 3,4 Million
Suspected of causing cancer, titanium dioxide, a white colouring agent, has been banned from food in Switzerland and Europe since last year. Impossible Materials, a spin-off from the University of Fribourg, has just raised CHF 3.4 million to develop a cellulose-based alternative. The round, which was led by Mission Possible Capital, was supported by Big Idea…
Read MoreHorizon Europe for Swiss Researchers
Swiss entities can participate in most Horizon Europe calls. Funding is provided by the Swiss government as long as Switzerland is not associated to the programme. The European programme for research and innovation, ‘Horizon Europe’, has a total of €95.5 billion with which to fund ground-breaking research that will impact society at all…
Read MoreTech4Eva selected 16 projects for its 2023 programme
16 projects have been selected for the 2023 programme Tech4Eva is an EPFL Innovation Park and Groupe Mutuel initiative that aims at creating a long-term impact for FemTech startups and a global FemTech Community. The 2023 international cohort was selected from a total of 147 applications from 40 countries. Since the start of the…
Read More